SandboxAQ Contributes to OpenFold Consortium's Newly Released OpenFold3 Model
OpenFold3, including key contributions from SandboxAQ, predicts the shape and structure of protein-molecular complexes
Leveraging its software expertise in AI model building, computational chemistry, and AI simulation, SandboxAQ's contributions help enable OpenFold to accurately predict protein-molecule structures, capabilities essential for commercial drug discovery. As the most extensively trained public co-folding model in existence, OpenFold3 will seed an ecosystem of AI drug discovery capabilities, including several to be released by SandboxAQ over the coming months.
"SandboxAQ has made significant contributions to the OpenFold Consortium that have greatly enhanced both the infrastructure and capabilities of the OpenFold ecosystem, raising the bar for what's possible with AI-powered in silico drug discovery," said Dr.
Innovations based on OpenFold3 join SandboxAQ's portfolio of pioneering Large Quantitative Models (LQMs), grounded in first-principle mathematical equations governing physics, chemistry, biology, and pharmacology, rather than existing text or literature found online. LQMs enable broad exploration of chemical space, rapid identification or design of novel molecular compounds not currently documented and optimization of entire drug portfolios in days instead of months or years.
"SandboxAQ is committed to transforming drug discovery and accelerating the development of novel therapies through AI and advanced technologies," said
For more information on OpenFold3 visit www.sandboxaq.com/openfold3 or email [email protected]. Organizations can access the preview of OpenFold3 code on Github, Docker image and model checkpoint through HuggingFace, and interface hosted versions through OpenFold Consortium partner, Tamarind Bio, and a locally deployable version through OpenFold Consortium partner Apheris.
About SandboxAQ
SandboxAQ is a B2B company delivering solutions at the intersection of AI and quantum techniques. The company's Large Quantitative Models (LQMs) deliver critical advances in life sciences, navigation, and other sectors. The company emerged from Alphabet Inc. as an independent, growth-backed company funded by leading investors and strategic partners including funds and accounts advised by T. Rowe Price Associates, Inc.,
About OpenFold Consortium
OpenFold is a non-profit AI research consortium of academic and industry partners whose goal is to develop free and open-source software tools for biology and drug discovery, hosted as a project of the Open Molecular Software Foundation. Membership is encouraged among Biotech, Pharma, Synthetic Bio, Software/Tech, and non-profit research organizations. For more information about OpenFold Consortium and its initiatives, please visit: https://openfold.io/
View original content to download multimedia:https://www.prnewswire.com/news-releases/sandboxaq-contributes-to-openfold-consortiums-newly-released-openfold3-model-302596951.html
SOURCE SandboxAQ
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baidu's Apollo Go Expands European Footprint as AmiGo, in Partnership with PostBus, Receives Level 4 Regulatory Approval in Switzerland
- Nextech3D.ai to Host Livestream Shareholder Update on Q4 Results, Audited FY2026 Financials, and AI Platform Growth Outlook
- Scilex Holding Company (“Scilex”) Confirms the Previously Announced Payment Date of June 15, 2026 for the Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock an
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Bridgewater Associates, S3Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share